Pharma Mar S.A. (PHMMF)
Pharma Mar S.A. Statistics
Share Statistics
Pharma Mar S.A. has 17.58M shares outstanding. The number of shares has increased by -1.48% in one year.
| Shares Outstanding | 17.58M |
| Shares Change (YoY) | -1.48% |
| Shares Change (QoQ) | 0.39% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 13.17M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 52.56 and the forward PE ratio is null. Pharma Mar S.A.'s PEG ratio is 0.02.
| PE Ratio | 52.56 |
| Forward PE | n/a |
| PS Ratio | 7.85 |
| Forward PS | n/a |
| PB Ratio | 6.59 |
| P/FCF Ratio | -144.8 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Pharma Mar S.A. has an Enterprise Value (EV) of 1.36B.
| EV / Sales | 7.78 |
| EV / EBITDA | 64.11 |
| EV / EBIT | 225.81 |
| EV / FCF | -143.51 |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.03 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 2.41 |
| Debt / FCF | -5.39 |
| Interest Coverage | 2.62 |
Financial Efficiency
Return on Equity is 12.54% and Return on Invested Capital is 5.09%.
| Return on Equity | 12.54% |
| Return on Assets | 7.47% |
| Return on Invested Capital | 5.09% |
| Revenue Per Employee | $349.71K |
| Profits Per Employee | $52.25K |
| Employee Count | 500 |
| Asset Turnover | 0.5 |
| Inventory Turnover | 0.16 |
Taxes
| Income Tax | -14.14M |
| Effective Tax Rate | -117.98% |
Stock Price Statistics
The stock price has increased by 228.42% in the last 52 weeks. The beta is 0.06, so Pharma Mar S.A.'s price volatility has been higher than the market average.
| Beta | 0.06 |
| 52-Week Price Change | 228.42% |
| 50-Day Moving Average | 94.61 |
| 200-Day Moving Average | 71.63 |
| Relative Strength Index (RSI) | 18.36 |
| Average Volume (20 Days) | 39 |
Income Statement
In the last 12 months, Pharma Mar S.A. had revenue of 174.85M and earned 26.13M in profits. Earnings per share was 1.49.
| Revenue | 174.85M |
| Gross Profit | 166.67M |
| Operating Income | 6.47M |
| Net Income | 26.13M |
| EBITDA | 21.23M |
| EBIT | 14.45M |
| Earnings Per Share (EPS) | 1.49 |
Balance Sheet
The company has 63.24M in cash and 51.08M in debt, giving a net cash position of 12.16M.
| Cash & Cash Equivalents | 63.24M |
| Total Debt | 51.08M |
| Net Cash | 12.16M |
| Retained Earnings | 168.38M |
| Total Assets | 349.64M |
| Working Capital | 167.55M |
Cash Flow
In the last 12 months, operating cash flow was 6.03M and capital expenditures -15.51M, giving a free cash flow of -9.48M.
| Operating Cash Flow | 6.03M |
| Capital Expenditures | -15.51M |
| Free Cash Flow | -9.48M |
| FCF Per Share | -0.54 |
Margins
Gross margin is 95.32%, with operating and profit margins of 3.7% and 14.94%.
| Gross Margin | 95.32% |
| Operating Margin | 3.7% |
| Pretax Margin | 6.85% |
| Profit Margin | 14.94% |
| EBITDA Margin | 12.14% |
| EBIT Margin | 3.7% |
| FCF Margin | -5.42% |
Dividends & Yields
PHMMF pays an annual dividend of $0.7, which amounts to a dividend yield of 2.24%.
| Dividend Per Share | $0.70 |
| Dividend Yield | 2.24% |
| Dividend Growth (YoY) | 0.43% |
| Payout Ratio | 54.53% |
| Earnings Yield | 1.9% |
| FCF Yield | -0.69% |
Analyst Forecast
Currently there are no analyst rating for PHMMF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jul 22, 2020. It was a backward split with a ratio of 1:12.
| Last Split Date | Jul 22, 2020 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | 8.46 |
| Piotroski F-Score | 6 |